The first UK isolate of 'Bordetella ansorpii' from an immunocompromised patient

Norman K Fry; John Duncan; Henry Malnick; Paul M Cockcroft

doi:10.1099/jmm.0.47078-0

The first UK isolate of 'Bordetella ansorpii' from an immunocompromised patient

J Med Microbiol. 2007 Jul;56(Pt 7):993-995. doi: 10.1099/jmm.0.47078-0.

Authors

Norman K Fry¹, John Duncan¹, Henry Malnick², Paul M Cockcroft³

Affiliations

¹ Respiratory and Systemic Infection Laboratory, Health Protection Agency Centre for Infections, London, UK.
² Laboratory of HealthCare Associated Infection, Health Protection Agency Centre for Infections, London, UK.
³ Department of Clinical Microbiology, St Mary's Hospital, Portsmouth, UK.

PMID: 17577067
DOI: 10.1099/jmm.0.47078-0

Abstract

What is believed to be the first clinical isolate of 'Bordetella ansorpii' in the UK from an immunocompromised patient is described. The only previously documented isolation of 'B. ansorpii' was following the initial culture of a single strain from an epidermal cyst of a patient in Korea.

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Bacterial Outer Membrane Proteins / genetics
Bacterial Proteins / genetics
Bordetella / classification*
Bordetella / genetics
Bordetella / isolation & purification*
Bordetella Infections / epidemiology*
Bordetella Infections / microbiology*
DNA, Ribosomal / analysis
Humans
Immunocompromised Host*
Male
Molecular Sequence Data
RNA, Ribosomal, 16S / genetics
Receptors, Cell Surface / genetics
Sequence Analysis, DNA
United Kingdom / epidemiology

Substances

Bacterial Outer Membrane Proteins
Bacterial Proteins
DNA, Ribosomal
RNA, Ribosomal, 16S
Receptors, Cell Surface
RisA protein, Bordetella
OMPA outer membrane proteins

Associated data

GENBANK/AM275334
GENBANK/AM275335
GENBANK/AM275336